Reprint

Fungal Biotechnology and Application 2.0

Edited by
April 2024
184 pages
  • ISBN978-3-7258-0670-6 (Hardback)
  • ISBN978-3-7258-0669-0 (PDF)

This book is a reprint of the Special Issue Fungal Biotechnology and Application 2.0 that was published in

Biology & Life Sciences
Public Health & Healthcare
Summary

This reprint published both original studies and literature reviews that describe the biotechnology and advanced applications of fungi, which are beneficial or harmful to human beings. It reported current fungal biotechnology and the industrial application of fungi in the fields of cosmetics, food, and pharmaceuticals. The following topics have been covered in this reprint: the application of fungi in all kinds of industries (e.g., scientific research, fermentation for cosmetic ingredients and pharmaceuticals, and food); fungal secondary metabolites and metabolic flow analysis; bioprospecting of novel fungi from specific environments; mechanisms of pathogenic fungal infection and its prevention and treatment; ecology, morphological, and ultrastructural diversity of fungi; cultivation and utilization of medicinal or edible mushrooms.

Format
  • Hardback
License
© 2024 by the authors; CC BY-NC-ND license
Keywords
Pichia kudriavzevii; fiber degradation; rumen fermentation; microbial community composition; rumen native yeast; non-Saccharomyces yeast; Miang; byproduct valorization; healthy beverage; fermentation; mycoremediation; bioremediation; textile; dye; white rot; brown rot; Hypholoma; conidial size; germination; granule; growth; Metarhizium brunneum; temperature; virulence; marine-derived fungi; amylase; starch hydrolysis; enzyme activity; thermal and pH stability; endophytes; Amazonian host; phenolic compounds; fungal metabolites; bioprospecting; fungal transgenic; 20E; deactivation; pathogenicity; barley bran; olive mill pomace; packed-bed bioreactor; partial purification; solid-state fermentation; Trichoderma spp.; xylanase; Yarrowia lipolytica; genome editing; CRISPR/Cas9; Mushrooms; anti-aging; age-related disease; cellular mechanisms; bioactive compounds